Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Monoderm bacteria: the new frontier for type IV pilus biology.

Pelicic V.

Mol Microbiol. 2019 Dec;112(6):1674-1683. doi: 10.1111/mmi.14397. Epub 2019 Oct 8. Review.

2.

Global biochemical and structural analysis of the type IV pilus from the Gram-positive bacterium Streptococcus sanguinis.

Berry JL, Gurung I, Anonsen JH, Spielman I, Harper E, Hall AMJ, Goosens VJ, Raynaud C, Koomey M, Biais N, Matthews S, Pelicic V.

J Biol Chem. 2019 Apr 26;294(17):6796-6808. doi: 10.1074/jbc.RA118.006917. Epub 2019 Mar 5.

3.

Reconstitution of a minimal machinery capable of assembling periplasmic type IV pili.

Goosens VJ, Busch A, Georgiadou M, Castagnini M, Forest KT, Waksman G, Pelicic V.

Proc Natl Acad Sci U S A. 2017 Jun 20;114(25):E4978-E4986. doi: 10.1073/pnas.1618539114. Epub 2017 Jun 6.

4.

Cloning-independent markerless gene editing in Streptococcus sanguinis: novel insights in type IV pilus biology.

Gurung I, Berry JL, Hall AMJ, Pelicic V.

Nucleic Acids Res. 2017 Apr 7;45(6):e40. doi: 10.1093/nar/gkw1177.

5.

A Comparative Structure/Function Analysis of Two Type IV Pilin DNA Receptors Defines a Novel Mode of DNA Binding.

Berry JL, Xu Y, Ward PN, Lea SM, Matthews SJ, Pelicic V.

Structure. 2016 Jun 7;24(6):926-34. doi: 10.1016/j.str.2016.04.001. Epub 2016 May 5.

6.

Functional analysis of an unusual type IV pilus in the Gram-positive Streptococcus sanguinis.

Gurung I, Spielman I, Davies MR, Lala R, Gaustad P, Biais N, Pelicic V.

Mol Microbiol. 2016 Jan;99(2):380-92. doi: 10.1111/mmi.13237. Epub 2015 Oct 27.

7.

Exceptionally widespread nanomachines composed of type IV pilins: the prokaryotic Swiss Army knives.

Berry JL, Pelicic V.

FEMS Microbiol Rev. 2015 Jan;39(1):134-54. doi: 10.1093/femsre/fuu001. Epub 2014 Dec 4. Review.

8.

Functional analysis of the interdependence between DNA uptake sequence and its cognate ComP receptor during natural transformation in Neisseria species.

Berry JL, Cehovin A, McDowell MA, Lea SM, Pelicic V.

PLoS Genet. 2013;9(12):e1004014. doi: 10.1371/journal.pgen.1004014. Epub 2013 Dec 19.

9.

Temperature triggers immune evasion by Neisseria meningitidis.

Loh E, Kugelberg E, Tracy A, Zhang Q, Gollan B, Ewles H, Chalmers R, Pelicic V, Tang CM.

Nature. 2013 Oct 10;502(7470):237-40. doi: 10.1038/nature12616. Epub 2013 Sep 25.

10.

Specific DNA recognition mediated by a type IV pilin.

Cehovin A, Simpson PJ, McDowell MA, Brown DR, Noschese R, Pallett M, Brady J, Baldwin GS, Lea SM, Matthews SJ, Pelicic V.

Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):3065-70. doi: 10.1073/pnas.1218832110. Epub 2013 Feb 5.

11.

Large-scale study of the interactions between proteins involved in type IV pilus biology in Neisseria meningitidis: characterization of a subcomplex involved in pilus assembly.

Georgiadou M, Castagnini M, Karimova G, Ladant D, Pelicic V.

Mol Microbiol. 2012 Jun;84(5):857-73. doi: 10.1111/j.1365-2958.2012.08062.x. Epub 2012 Apr 24.

12.

A network of enzymes involved in repair of oxidative DNA damage in Neisseria meningitidis.

Nagorska K, Silhan J, Li Y, Pelicic V, Freemont PS, Baldwin GS, Tang CM.

Mol Microbiol. 2012 Mar;83(5):1064-1079. doi: 10.1111/j.1365-2958.2012.07989.x. Epub 2012 Feb 15.

13.

Testing the vaccine potential of PilV, PilX and ComP, minor subunits of Neisseria meningitidis type IV pili.

Cehovin A, Kroll JS, Pelicic V.

Vaccine. 2011 Sep 16;29(40):6858-65. doi: 10.1016/j.vaccine.2011.07.060. Epub 2011 Jul 29.

14.

Structure/function analysis of Neisseria meningitidis PilW, a conserved protein that plays multiple roles in type IV pilus biology.

Szeto TH, Dessen A, Pelicic V.

Infect Immun. 2011 Aug;79(8):3028-35. doi: 10.1128/IAI.05313-11. Epub 2011 Jun 6.

15.

Sequence conservation of pilus subunits in Neisseria meningitidis.

Cehovin A, Winterbotham M, Lucidarme J, Borrow R, Tang CM, Exley RM, Pelicic V.

Vaccine. 2010 Jul 5;28(30):4817-26. doi: 10.1016/j.vaccine.2010.04.065. Epub 2010 May 8.

16.

Systematic functional analysis reveals that a set of seven genes is involved in fine-tuning of the multiple functions mediated by type IV pili in Neisseria meningitidis.

Brown DR, Helaine S, Carbonnelle E, Pelicic V.

Infect Immun. 2010 Jul;78(7):3053-63. doi: 10.1128/IAI.00099-10. Epub 2010 May 3.

17.

NeMeSys: a biological resource for narrowing the gap between sequence and function in the human pathogen Neisseria meningitidis.

Rusniok C, Vallenet D, Floquet S, Ewles H, Mouzé-Soulama C, Brown D, Lajus A, Buchrieser C, Médigue C, Glaser P, Pelicic V.

Genome Biol. 2009;10(10):R110. doi: 10.1186/gb-2009-10-10-r110. Epub 2009 Oct 9.

18.

Structure of a widely conserved type IV pilus biogenesis factor that affects the stability of secretin multimers.

Trindade MB, Job V, Contreras-Martel C, Pelicic V, Dessen A.

J Mol Biol. 2008 May 16;378(5):1031-9. doi: 10.1016/j.jmb.2008.03.028. Epub 2008 Mar 19.

19.

Type IV pili: e pluribus unum?

Pelicic V.

Mol Microbiol. 2008 May;68(4):827-37. doi: 10.1111/j.1365-2958.2008.06197.x. Epub 2008 Apr 8. Review.

20.

3D structure/function analysis of PilX reveals how minor pilins can modulate the virulence properties of type IV pili.

Helaine S, Dyer DH, Nassif X, Pelicic V, Forest KT.

Proc Natl Acad Sci U S A. 2007 Oct 2;104(40):15888-93. Epub 2007 Sep 24.

21.

Alternative Neisseria spp. type IV pilin glycosylation with a glyceramido acetamido trideoxyhexose residue.

Chamot-Rooke J, Rousseau B, Lanternier F, Mikaty G, Mairey E, Malosse C, Bouchoux G, Pelicic V, Camoin L, Nassif X, Duménil G.

Proc Natl Acad Sci U S A. 2007 Sep 11;104(37):14783-8. Epub 2007 Sep 5.

22.

Recent advances in the expression, evolution, and dynamics of prokaryotic genomes.

Arraiano CM, Bamford J, Brüssow H, Carpousis AJ, Pelicic V, Pflüger K, Polard P, Vogel J.

J Bacteriol. 2007 Sep;189(17):6093-100. Epub 2007 Jun 29. No abstract available.

24.

Meningococcal adhesion suppresses proapoptotic gene expression and promotes expression of genes supporting early embryonic and cytoprotective signaling of human endothelial cells.

Linhartova I, Basler M, Ichikawa J, Pelicic V, Osicka R, Lory S, Nassif X, Sebo P.

FEMS Microbiol Lett. 2006 Oct;263(1):109-18.

25.

PilX, a pilus-associated protein essential for bacterial aggregation, is a key to pilus-facilitated attachment of Neisseria meningitidis to human cells.

Hélaine S, Carbonnelle E, Prouvensier L, Beretti JL, Nassif X, Pelicic V.

Mol Microbiol. 2005 Jan;55(1):65-77.

26.
27.

Neisseria meningitidis RTX proteins are not required for virulence in infant rats.

Forman S, Linhartova I, Osicka R, Nassif X, Sebo P, Pelicic V.

Infect Immun. 2003 Apr;71(4):2253-7.

28.

Large-scale analysis of the meningococcus genome by gene disruption: resistance to complement-mediated lysis.

Geoffroy MC, Floquet S, Métais A, Nassif X, Pelicic V.

Genome Res. 2003 Mar;13(3):391-8.

29.

Phospholipases C are involved in the virulence of Mycobacterium tuberculosis.

Raynaud C, Guilhot C, Rauzier J, Bordat Y, Pelicic V, Manganelli R, Smith I, Gicquel B, Jackson M.

Mol Microbiol. 2002 Jul;45(1):203-17.

30.

Culture at high density improves the ability of human macrophages to control mycobacterial growth.

Boechat N, Bouchonnet F, Bonay M, Grodet A, Pelicic V, Gicquel B, Hance AJ.

J Immunol. 2001 May 15;166(10):6203-11.

31.

Mutagenesis of Neisseria meningitidis by in vitro transposition of Himar1 mariner.

Pelicic V, Morelle S, Lampe D, Nassif X.

J Bacteriol. 2000 Oct;182(19):5391-8.

32.

Towards deciphering the Helicobacter pylori cytotoxin.

Reyrat JM, Pelicic V, Papini E, Montecucco C, Rappuoli R, Telford JL.

Mol Microbiol. 1999 Oct;34(2):197-204. Review.

33.

Use of fluorescence induction and sucrose counterselection to identify Mycobacterium tuberculosis genes expressed within host cells.

Triccas JA, Berthet FX, Pelicic V, Gicquel B.

Microbiology. 1999 Oct;145 ( Pt 10):2923-30.

PMID:
10537214
34.

Helicobacter pylori VacA cytotoxin associated with the bacteria increases epithelial permeability independently of its vacuolating activity.

Pelicic V, Reyrat JM, Sartori L, Pagliaccia C, Rappuoli R, Telford JL, Montecucco C, Papini E.

Microbiology. 1999 Aug;145 ( Pt 8):2043-50.

PMID:
10463170
35.

3D imaging of the 58 kDa cell binding subunit of the Helicobacter pylori cytotoxin.

Reyrat JM, Lanzavecchia S, Lupetti P, de Bernard M, Pagliaccia C, Pelicic V, Charrel M, Ulivieri C, Norais N, Ji X, Cabiaux V, Papini E, Rappuoli R, Telford JL.

J Mol Biol. 1999 Jul 9;290(2):459-70.

PMID:
10390344
36.

Effect of stimulation of human macrophages on intracellular survival of Mycobacterium bovis Bacillus Calmette-Guerin. Evaluation with a mycobacterial reporter strain.

Bonay M, Bouchonnet F, Pelicic V, Lagier B, Grandsaigne M, Lecossier D, Grodet A, Vokurka M, Gicquel B, Hance AJ.

Am J Respir Crit Care Med. 1999 May;159(5 Pt 1):1629-37.

PMID:
10228137
37.

Tn611 transposon mutagenesis in Mycobacterium smegmatis using a temperature-sensitive delivery system.

Pérez E, Gavigan JA, Otal I, Guilhot C, Pelicic V, Giquel B, Martín C.

Methods Mol Biol. 1998;101:187-98. No abstract available.

PMID:
9921478
38.

Attenuation of virulence by disruption of the Mycobacterium tuberculosis erp gene.

Berthet FX, Lagranderie M, Gounon P, Laurent-Winter C, Ensergueix D, Chavarot P, Thouron F, Maranghi E, Pelicic V, Portnoï D, Marchal G, Gicquel B.

Science. 1998 Oct 23;282(5389):759-62.

39.

Identification of genetic loci implicated in the survival of Mycobacterium smegmatis in human mononuclear phagocytes.

Lagier B, Pelicic V, Lecossier D, Prod'hom G, Rauzier J, Guilhot C, Gicquel B, Hance AJ.

Mol Microbiol. 1998 Jul;29(2):465-75.

40.

Counterselectable markers: untapped tools for bacterial genetics and pathogenesis.

Reyrat JM, Pelicic V, Gicquel B, Rappuoli R.

Infect Immun. 1998 Sep;66(9):4011-7. Review. No abstract available.

41.

Genetic advances for studying Mycobacterium tuberculosis pathogenicity.

Pelicic V, Reyrat JM, Gicquel B.

Mol Microbiol. 1998 May;28(3):413-20. Review.

42.

A reliable amplification technique for the characterization of genomic DNA sequences flanking insertion sequences.

Prod'hom G, Lagier B, Pelicic V, Hance AJ, Gicquel B, Guilhot C.

FEMS Microbiol Lett. 1998 Jan 1;158(1):75-81.

43.

Efficient allelic exchange and transposon mutagenesis in Mycobacterium tuberculosis.

Pelicic V, Jackson M, Reyrat JM, Jacobs WR Jr, Gicquel B, Guilhot C.

Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):10955-60.

44.

Contribution of beta-lactamase production to the resistance of mycobacteria to beta-lactam antibiotics.

Quinting B, Reyrat JM, Monnaie D, Amicosante G, Pelicic V, Gicquel B, Frère JM, Galleni M.

FEBS Lett. 1997 Apr 14;406(3):275-8.

46.

Positive selection of allelic exchange mutants in Mycobacterium bovis BCG.

Pelicic V, Reyrat JM, Gicquel B.

FEMS Microbiol Lett. 1996 Nov 1;144(2-3):161-6.

PMID:
8900059
47.

Generation of unmarked directed mutations in mycobacteria, using sucrose counter-selectable suicide vectors.

Pelicic V, Reyrat JM, Gicquel B.

Mol Microbiol. 1996 Jun;20(5):919-25.

PMID:
8809745
48.

Expression of the Bacillus subtilis sacB gene confers sucrose sensitivity on mycobacteria.

Pelicic V, Reyrat JM, Gicquel B.

J Bacteriol. 1996 Feb;178(4):1197-9.

Supplemental Content

Loading ...
Support Center